CAT No: CP25334
CAS No:13734-40-2
Synonyms/Alias:Boc-Thr(tBu)-OH;13734-40-2;Boc-O-tert-butyl-L-threonine;(2S,3R)-3-(tert-Butoxy)-2-((tert-butoxycarbonyl)amino)butanoicacid;PubChem12289;Boc-O-tert-Butyl-L-Thr-OH;15433_ALDRICH;AC1Q29D9;SCHEMBL2395128;15433_FLUKA;CTK3J8325;N-BOC-O-tert-butyl-L-threonine;LKRXXARJBFBMCE-BDAKNGLRSA-N;MolPort-001-793-127;ZINC2517036;ANW-43370;SBB066170;AKOS015895291;RTR-033627;VA50175;AJ-37018;AK-48832;AB0012778;DB-022912;TR-033627
Chemical Name:N-alpha-t-Butyloxycarbonyl-O-t-butyl-L-threonine
Boc-L-Thr(tBu)-OH is a Boc-protected L-threonine derivative bearing a tert-butyl-protected side-chain hydroxyl, providing orthogonal protection for peptide assembly workflows. The combination of a Boc group on the amino functionality and a tBu ether on the side-chain oxygen makes this building block well suited for controlled stepwise coupling and for preparing threonine-containing peptide segments with minimal side reactions. Researchers commonly select this protected amino acid when they need a stable, protected threonine residue that can be carried through peptide synthesis and later deprotected to reveal the native hydroxyl handle for downstream chemistry.
1. Solid-Phase Peptide Synthesis
Boc-L-Thr(tBu)-OH is used as a protected threonine building block in solid-phase peptide synthesis workflows where the side-chain hydroxyl must remain masked during chain elongation. Peptide synthesis groups and custom peptide manufacturers rely on this protection pattern to minimize side reactions from the threonine alcohol while maintaining a Boc-protected amino terminus for sequential coupling steps. The tert-butyl side-chain protection supports preparation of threonine-rich sequences and peptide fragments that require the threonine hydroxyl to be preserved until final deprotection and purification.
2. Threonine-Containing Segment Building
Boc-L-Thr(tBu)-OH serves as a practical intermediate for constructing threonine-containing peptide segments for solution-phase or hybrid peptide assembly strategies. Medicinal chemistry teams developing peptide leads often need reliable incorporation of protected threonine residues to control chemoselectivity during fragment condensation and to avoid undesired hydroxyl participation under coupling and activation conditions. By keeping both the amino group and the side-chain oxygen protected, this building block supports reproducible assembly of defined peptide architectures used in SAR studies, peptide mapping, and structure-function investigations.
3. Protected Hydroxyl Peptide Intermediates
Boc-L-Thr(tBu)-OH is frequently selected when the threonine side-chain hydroxyl must be retained as a protected functional group through multiple synthetic steps, including purification and intermediate handling. Chemical biology and protein research laboratories use threonine-containing protected intermediates to prepare peptides that later undergo controlled deprotection to regenerate the alcohol for subsequent derivatization or for generating native-like peptide material. This makes Boc-L-Thr(tBu)-OH a useful reagent for workflows where the threonine hydroxyl is a key chemical feature that should be introduced or unmasked at a specific stage rather than during early coupling steps.
4. Pharmaceutical Intermediate Development
Boc-L-Thr(tBu)-OH is also used in pharmaceutical intermediate development contexts where protected amino acid derivatives are required to build more complex peptide-like scaffolds or to prepare defined, protected fragments for downstream processing. Process development chemists and specialty chemical manufacturers value this reagent for its protected-group strategy that supports controlled handling of threonine functionality during multistep synthesis. The Boc/tBu protection pattern helps ensure that the threonine residue remains chemically protected while the rest of the intermediate is assembled, enabling consistent downstream conversion to the intended protected or deprotected forms required for further development.
2. Cationic cell-penetrating peptides are potent furin inhibitors
3. TMEM16F and dynamins control expansive plasma membrane reservoirs
5. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.